Association of adiponectin concentration with acute coronary syndrome types in diabetes mellitus: A cross-sectional study
Abstract
Diabetes Mellitus (DM) increases the risk of acute coronary syndrome (ACS). Adiponectin has been popular as a potential indicator for DM and ACS. Hypoadiponectinemia has an important role in the pathogenesis of cardiovascular disease associated with metabolic syndrome. A cross-sectional analytical study with simple random sampling was conducted at Dr. Wahidin Hospital. The study samples were diagnosed with DM and ACS. Data analysis was performed using chi-square tests and odds ratios (ORs). This study involved 88 subjects with DM and ACS who fulfilled the study’s eligibility criteria. The mean adiponectin concentration was 10.27 µg/ml. The subjects with the highest adiponectin concentration quartile (Q4) were those with STEMI (69.6%), and the difference was not statistically significant (chi-square, p>0.05). There is a significant association between dyslipidemia and adiponectin concentration (p<0.05), with the highest adiponectin concentration in the quartile (Q2) at 28.4%. Subjects with hypoadiponectinemia quartile (Q1–Q2) had 11.6 times higher risk of mortality (OR 11.647, 95% CI: 1.407–96.443, p=0.006). There is no significant association between adiponectin concentration and the type of ACS in DM subjects. Dyslipidemia was identified as the predominant risk factor affecting adiponectin concentration. A significant association was found between adiponectin concentration and mortality from acute coronary syndrome in diabetic subjects.